查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604657

人工角膜/角膜植入市场：按类型、适应症和最终用户分类 - 2025-2030 年全球预测

Artificial Cornea & Corneal Implant Market by Type (Artificial Cornea, Human Cornea), Disease Indication (Fuchs' Dystrophy, Fungal Keratitis, Keratoconus), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年人工角膜和角膜植入市场价值为5.2879亿美元，预计2024年将达到5.9313亿美元，复合年增长率为12.65%，到2030年将达到12.1756亿美元。

人工角膜和角膜植入市场是医疗设备业的一个专门领域，专注于开拓和製造在因疾病、受伤或先天性疾病而受损时替代和修復角膜的产品。角膜假体是一种人工替代品，其功能与天然角膜相似，而角膜植入则透过改变现有角膜的形状和结构来改善视力。对这些创新的需求源自于角膜失明的日益流行，该疾病困扰着全世界数百万人，迫切需要可及且有效的治疗方法。它具有广泛的应用范围，包括针对圆锥角膜（角膜逐渐变薄并变成圆锥形）等疾病的矫正手术，以及需要完全角膜置换的患者。最终使用领域主要包括医院、眼科诊所和专业眼科护理中心。影响成长的关键因素包括生物材料和 3D 列印技术的进步、先进眼科护理意识和可及性的提高以及政府的支持措施。最新的机会在于医疗保健需求未满足的新兴市场，这些市场对创新眼保健解决方案的需求正在迅速增加，对新医疗设备的监管支持也在增加。然而，挑战仍然存在，包括高成本、资源匮乏环境中的可用性有限以及与监管核准相关的复杂性。技术创新的时机已经成熟，包括开发生物相容性和持久的植入材料，改进手术技术以改善术后结果，以及透过扩大远端医疗在术前和术后护理中的作用来提高可及性。该市场的特点是技术进步快、注重以患者为中心的结果，以及生物技术公司和医疗保健提供者之间建立策略联盟以加强分销网路和市场渗透的潜力。建议包括优先投资新材料的研发、利用数位健康平台以及探索策略合作伙伴关係以降低成本并提高产品采用率。

主要市场统计
基准年[2023] 5.2879 亿美元
预计年份 [2024] 5.9313 亿美元
预测年份 [2030] 1,217.56 百万美元
复合年增长率（%） 12.65%

市场动态：快速发展的人工角膜和角膜植入市场的关键市场洞察

人工角膜和角膜植入市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 人群中角膜感染疾病和疾病的盛行率不断增加
    • 政府措施激增
    • 全球角膜捐赠者数量增加
  • 市场限制因素
    • 人工角膜和角膜植入相关的高成本
  • 市场机会
    • 移植手术新技术的出现与进步
    • 获得认证的角膜植入商业化新兴企业的兴起
  • 市场挑战
    • 对人工角膜移植高风险的担忧

波特五力：开拓人工角膜和角膜植入市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解人工角膜和角膜植入市场的外部影响

外部宏观环境因素在塑造人工角膜和角膜植入市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解人工角膜/角膜植入市场的竞争状况

对角膜假体和角膜植入市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵人工角膜和角膜植入市场供应商绩效评估

FPNV定位矩阵是评估角膜假体和角膜植入市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，描绘人工角膜和角膜植入市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对人造角膜和角膜植入市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人群中角膜感染疾病和疾病的盛行率增加
      • 政府对视力障碍的管理力道迅速加大
      • 世界各地的角膜捐赠者不断增加
    • 抑制因素
      • 角膜假体/角膜植入相关的高成本
    • 机会
      • 植入手术新技术的出现与进展
      • 获得角膜植入商业化认证的Start-Ups的崛起
    • 任务
      • 对人工角膜移植高风险的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章人工角膜/角膜植入市场：依类型

  • 人工角膜
  • 人类角膜

第七章人工角膜/角膜植入市场：依疾病适应症

  • 福克斯营养不良症
  • 霉菌性角膜炎
  • 圆锥角膜

第八章人工角膜/角膜植入市场：依最终用户分类

  • 医院
  • 专科诊所及门诊手术中心

第九章 北美、南美人工角膜及角膜植入市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区人工角膜及角膜植入市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲人工角膜和角膜植入市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Addition Technology Inc.
  • Advancing Sight Network
  • AJL Ophthalmic SA
  • Allotex, Inc.
  • Aurolab
  • Bausch & Lomb Incorporated
  • Beijing Microkpro Medical Instrument Co., Ltd
  • Cornea Biosciences Inc.
  • CorneaGen Inc.
  • CorNeat Vision Ltd.
  • DIOPTEX GmbH
  • Eye Bank Association of America
  • EyeYon Medical Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Florida Lions Eye Bank
  • KeraMed, Inc.
  • LV Prasad Eye Institute
  • LinkoCare Life Sciences AB
  • Mediphacos
  • MIOK Keratoprosthesis
  • Pfizer, Inc.
  • Presbia PLC
  • SMR Ophthalmic
  • The Cooper Companies, Inc.
Product Code: MRR-50124643734D

The Artificial Cornea & Corneal Implant Market was valued at USD 528.79 million in 2023, expected to reach USD 593.13 million in 2024, and is projected to grow at a CAGR of 12.65%, to USD 1,217.56 million by 2030.

The artificial cornea and corneal implant market is a specialized segment within the medical devices industry, focused on developing and manufacturing products to replace or repair the cornea when damaged due to disease, injury, or congenital conditions. The artificial cornea is a synthetic substitute designed to function similarly to a natural cornea, while corneal implants are used to improve visual acuity by altering the shape or structure of the existing cornea. The necessity of these innovations arises from the growing prevalence of corneal blindness, which afflicts millions globally, creating a compelling need for accessible, effective treatments. Applications are broad, encompassing corrective surgeries for conditions like keratoconus, where the cornea progressively thins and changes to a more conical shape, and for patients needing a full corneal replacement. End-use sectors primarily include hospitals, ophthalmic clinics, and specialty eye care centers. Key influencing growth factors include advances in biomaterials and 3D printing technology, increasing awareness and accessibility of advanced ophthalmic care, and supportive government initiatives. The latest opportunities lie in emerging markets with unmet healthcare needs, where the demand for innovative eye care solutions is acute, and enhanced regulatory support for novel medical devices. However, challenges persist, including high costs, limited availability in low-resource settings, and the complexity involved in regulatory approvals. Innovation is ripe in developing bio-compatible and longer-lasting implant materials, enhancing post-surgical outcomes through improved surgical techniques, and expanding telemedicine's role in pre- and post-operative care to increase accessibility. The market is characterized by a rapid pace of technological advancement, a focus on patient-centered outcomes, and the potential for strategic partnerships between biotechnology firms and health care providers to enhance distribution networks and market penetration. Recommendations include prioritizing investments in R&D for novel materials, leveraging digital health platforms, and exploring strategic collaborations to mitigate costs and enhance product outreach.

KEY MARKET STATISTICS
Base Year [2023] USD 528.79 million
Estimated Year [2024] USD 593.13 million
Forecast Year [2030] USD 1,217.56 million
CAGR (%) 12.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Cornea & Corneal Implant Market

The Artificial Cornea & Corneal Implant Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of corneal infections and diseases among population
    • Surge in government initiatives to manage vision impairment
    • Increasing number of cornea donors worldwide
  • Market Restraints
    • High costs associated with artificial cornea & corneal implant
  • Market Opportunities
    • Emergence of new technologies and advancements in implantation procedures
    • Rise of startups with certifications for cornea implant commercialization
  • Market Challenges
    • Concerns regarding high risk in the grafting artificial cornea implant

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Cornea & Corneal Implant Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Cornea & Corneal Implant Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Cornea & Corneal Implant Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Cornea & Corneal Implant Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Cornea & Corneal Implant Market

A detailed market share analysis in the Artificial Cornea & Corneal Implant Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Cornea & Corneal Implant Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Cornea & Corneal Implant Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Cornea & Corneal Implant Market

A strategic analysis of the Artificial Cornea & Corneal Implant Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Cornea & Corneal Implant Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Addition Technology Inc., Advancing Sight Network, AJL Ophthalmic S.A., Allotex, Inc., Aurolab, Bausch & Lomb Incorporated, Beijing Microkpro Medical Instrument Co., Ltd, Cornea Biosciences Inc., CorneaGen Inc., CorNeat Vision Ltd., DIOPTEX GmbH, Eye Bank Association of America, EyeYon Medical Ltd., F. Hoffmann-La Roche Ltd., Florida Lions Eye Bank, KeraMed, Inc., L V Prasad Eye Institute, LinkoCare Life Sciences AB, Mediphacos, MIOK Keratoprosthesis, Pfizer, Inc., Presbia PLC, SMR Ophthalmic, and The Cooper Companies, Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Cornea & Corneal Implant Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Artificial Cornea and Human Cornea.
  • Based on Disease Indication, market is studied across Fuchs' Dystrophy, Fungal Keratitis, and Keratoconus.
  • Based on End User, market is studied across Hospitals and Specialty Clinics & Ambulatory Surgical Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of corneal infections and diseases among population
      • 5.1.1.2. Surge in government initiatives to manage vision impairment
      • 5.1.1.3. Increasing number of cornea donors worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with artificial cornea & corneal implant
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of new technologies and advancements in implantation procedures
      • 5.1.3.2. Rise of startups with certifications for cornea implant commercialization
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding high risk in the grafting artificial cornea implant
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Cornea & Corneal Implant Market, by Type

  • 6.1. Introduction
  • 6.2. Artificial Cornea
  • 6.3. Human Cornea

7. Artificial Cornea & Corneal Implant Market, by Disease Indication

  • 7.1. Introduction
  • 7.2. Fuchs' Dystrophy
  • 7.3. Fungal Keratitis
  • 7.4. Keratoconus

8. Artificial Cornea & Corneal Implant Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Specialty Clinics & Ambulatory Surgical Centers

9. Americas Artificial Cornea & Corneal Implant Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Artificial Cornea & Corneal Implant Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Cornea & Corneal Implant Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Addition Technology Inc.
  • 3. Advancing Sight Network
  • 4. AJL Ophthalmic S.A.
  • 5. Allotex, Inc.
  • 6. Aurolab
  • 7. Bausch & Lomb Incorporated
  • 8. Beijing Microkpro Medical Instrument Co., Ltd
  • 9. Cornea Biosciences Inc.
  • 10. CorneaGen Inc.
  • 11. CorNeat Vision Ltd.
  • 12. DIOPTEX GmbH
  • 13. Eye Bank Association of America
  • 14. EyeYon Medical Ltd.
  • 15. F. Hoffmann-La Roche Ltd.
  • 16. Florida Lions Eye Bank
  • 17. KeraMed, Inc.
  • 18. L V Prasad Eye Institute
  • 19. LinkoCare Life Sciences AB
  • 20. Mediphacos
  • 21. MIOK Keratoprosthesis
  • 22. Pfizer, Inc.
  • 23. Presbia PLC
  • 24. SMR Ophthalmic
  • 25. The Cooper Companies, Inc.

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ARTIFICIAL CORNEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY HUMAN CORNEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY FUCHS' DYSTROPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY FUNGAL KERATITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOCONUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET, FPNV POSITIONING MATRIX, 2023